Who owns Cellectar Biosciences, Inc.? Owners, funding and legal record

Before you sign or pay

• Court and bankruptcy: No federal court case or bankruptcy filing found under Cellectar Biosciences, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
• Leadership changes: the latest reported is Andrew Gu, Director (Form 8-K filed 2026-05-18). Check you are dealing with the people now in charge.
• Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Stempoint Capital LP (filed 2026-08-14).

Who is behind it

Cellectar Biosciences, Inc.: incorporated in Delaware; business address in Florham Park, New Jersey; industry Pharmaceutical Preparations (Schedule 13G, 2026-08-14).

Officers and directors, each with the role and the filing that names them:

• James V. Caruso: Executive Officer, Director (Form D, 2023-09-22)
• Chad J. Kolean: Executive Officer (Form D, 2023-09-22)
• Jarrod Longcor: Executive Officer (Form D, 2023-09-22)
• Darrell Shane Lea: Executive Officer (Form D, 2023-09-22)
• Andrei Shustov: Executive Officer (Form D, 2023-09-22)
• Douglas J. Swirsky: Director (Form D, 2023-09-22)
• Asher Alban Chanan-Kahn: Director (Form D, 2023-09-22)
• Frederick W. Driscoll: Director (Form D, 2023-09-22)
• Stefan D. Loren: Director (Form D, 2023-09-22)
• John Neis: Director (Form D, 2023-09-22)

Money raised

Latest IPO step: Cellectar Biosciences, Inc. amended its IPO registration (S-1/A, 2026-05-29).

IPO filings: S-1/A, 2026-05-29, S-1, 2026-05-19, S-1, 2025-10-20, 424B4, 2025-07-02, S-1/A, 2025-06-30; ticker CLRB on Nasdaq Capital Market.

Related pages

Leadership changes5%+ holders

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

All companies

Not for employment, credit, insurance or tenancy decisions.